Powered by 
Google Übersetzer
Google Übersetzer
NEW YORK, NY / ACCESSWIRE / August 21, 2023 / Emergent Health Corp. (OTC PINK: EMGE), a curator, developer and marketer of products in the regenerative health space, announced today that on August 8, 2023, the majority of Series A Shareholders elected a new Board of Directors of Emergent Health Corp (“Emergent”) effective immediately.
The new Board of Directors/Officers consists of:
Jim Morrison, Chairman, CEO/President
James W. Zimbler
David Thielen
Sandy Lipkins
Lance Liberti, COO
The Bios of our new Board Members are as follows:
David Thielen: Mr. Thielen's career includes roles in Finance Management, Investment, Sales Management and Strategy Management as Vice President, CIO, CFO and CEO. Mr. Thielen is currently the Chief Investment Officer (CIO) and Chief Financial Officer (CFO) at publicly traded Resonate Blends, Inc. and is tasked with managing financial reporting, creating investment solutions to fund company initiatives, provide accurate and timely SEC filings, manage the overall public company strategies and serve as the investor liaison for corporate communication. He spent a majority of his executive career at DeRoyal Industries, a leading global medical manufacture, for more than eight years as Area Vice President and twenty-one (21) years overall in various executive roles. DeRoyal Industries serves hospitals, surgery centers and Integrated Healthcare Networks (IHN) throughout the United States, Europe and Asia. Prior to his current role at Resonate Blends, Inc., he has spent the past several years working with leading System Integrators in the federal government sector; including numerous mission critical programs at Northrop Grumman and Lockheed Martin, before founding Aspire Consulting Group ("Aspire") in 2015. Aspire is a Service-Disabled Veteran-Owned Small Business (SDVOSB) located in Washington, D.C. with emphasis in the federal, state and commercial sectors. Aspire specializes in innovative IT solutions targeting Business Process Engineering, Health IT, Software Integration and Digital Engagement. He currently serves as Vice Chairman of The Board at Aspire. Mr. Thielen holds a Bachelor of Science degree from Iowa State University.
Lance Liberti: As CEO and founder of Integrative Practice Solutions, Lance Liberti brings a lifetime of experience and demonstrated excellence to the executive team. After founding a nationwide healthcare advertising agency in his collegiate years, Mr. Liberti assumed the role of Chief Operating Officer of Spinal Aid Centers of America. During his tenure he expanded the national franchise network from 67 to 162 locations and recognition as the #2 medical service franchise in the world and the 91st fastest growing franchise of the new millennium (as rated by Entrepreneur Magazine in the 2007 Franchise 500 edition). It was at this time that Mr. Liberti suffered his own run-in with "bone-on-bone" contact osteoarthritis, the result of a high school football injury and failed prior reconstructive knee surgery. One of his Chiropractic clients introduced him to his father, a D.O. performing Hyalgan injections that saved his knee and eliminated the need for further surgical intervention. Amazed by the miraculous results and lack of awareness in the medical community that this treatment option even existed, Mr. Liberti partnered with this physician to open the first stand-alone Osteoarthritis specialty practice in southern NJ in 2009. In this facility Mr. Liberti co-developed the now patented Advanced Arthritis Relief Protocol (AARP Program), as well as the patient marketing and administrative business practices that drive the clinical and financial success of this protocol in the more than 200+ licensed locations in 40+ US states today.
Sandy P. Lipkins: Mr. Lipkins has over 20 plus years of venture capital, finance and sales experience. For the last 14 years, he has focused on the anti-aging/wellness sector. He has started numerous successful enterprises in the regenerative medical space which has required multiple levels of expertise in business development and strategic planning, as well as capital formation and executive management. Mr. Lipkins is passionate about promoting anti-aging, healthy lifestyle and bringing cutting edge regenerative medicine to the critical masses domestically and internationally. He has taken companies from incubation to revenues to setting up for sale or other liquidity events.
Jim Morrison, CEO of Emergent added “From the day we started this journey with Emergent Health, our goal has remained the same - to evolve Emergent into a world class marketer and manufacturer of the most cutting-edge products in the regenerative medicine space,” stated Jim Morrison, CEO of Emergent. “Our transition to 'Apollo Biowellness' is the next big step on that journey. We have assembled one of the most attractive portfolios in the industry and have positioned Apollo for dramatic growth. I am honored to announce the new Board of Directors and looking forward to the collaborative results that will come from working with these dynamic business minds."
On July 20, 2023, Emergent closed and withdrew its Regulation A Offering that had been filed with the SEC. This was due to the changing market conditions and the difficulty of raising additional capital with this Offering. As a result, Emergent is in the process of seeking other capital sources.
Accordingly, the previously announced transaction with Boustead Securities, involving the spin out of PharmaZu, Inc. (“PharmaZu”), has been abandoned. This was a result of changing market conditions which was determined by both parties.
As a result of these changes, Emergent has entered into a Plan and Agreement of Merger with Apollo Biowellness, Inc. (“Apollo”). Under the new Plan, Emergent will acquire Apollo and its subsidiaries Juventix Regenerative Medical, LLC (“Juventix”) and Integrative Practice Solutions, LLC (“IPS”), both located in Florida. Emergent is also creating Nanosthetic, Inc. (“Nanosthetic”), a fully certified laboratory for the manufacturing of regenerative products to be sold by the consolidated holding company.
On August 8, 2023, the Board of Directors also approved corporate actions to amend the name of Emergent Health Corp to Apollo Biowellness, Inc., in addition to approving a reverse stock split of its common stock in the amount of 5,000 to 1. These actions will not be effective until ratified by FINRA.
The Board of Directors expects these actions will allow the Company to effectively raise capital to expand its business plan. This updated business plan involves consolidating the Apollo subsidiaries into Emergent which already owns Evolutionary Biologics, Inc., an innovative brand in the regenerative and biologics sector along with PharmaZu. Also included in Emergent are Nanosthetic and the upcoming brand of Maximum Men’s Health. This consolidation and holding company name change to Apollo Biowellness, Inc. will create a synergistic company of cutting-edge regenerative health assets.
Apollo Biowellness Inc.
ABOUT EMERGENT HEALTH CORPORATION
Emergent curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through “Content Based Shopping” using “Influencers” to successfully position products throughout the United States and Internationally. Its subsidiaries: PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy, and Pet Wellness. It will also utilize Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Regen Biowellness is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emigrant’s Website and Social Media on Twitter and Linkedin.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
FOR MORE INFORMATION, PLEASE CONTACT:
Jim Morrison, CEO
